These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26806567)

  • 1. Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.
    Guerini-Rocco E; Piscuoglio S; Ng CK; Geyer FC; De Filippo MR; Eberle CA; Akram M; Fusco N; Ichihara S; Sakr RA; Yatabe Y; Vincent-Salomon A; Rakha EA; Ellis IO; Wen YH; Weigelt B; Schnitt SJ; Reis-Filho JS
    J Pathol; 2016 Apr; 238(5):677-88. PubMed ID: 26806567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast.
    Radner M; van Luttikhuizen JL; Bartels S; Bublitz J; Grote I; Rieger L; Christgen H; Stark H; Werlein C; Lafos M; Steinemann D; Lehmann U; Christgen M; Kreipe H
    J Pathol Clin Res; 2021 May; 7(3):220-232. PubMed ID: 33382535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
    Guerini-Rocco E; Hodi Z; Piscuoglio S; Ng CK; Rakha EA; Schultheis AM; Marchiò C; da Cruz Paula A; De Filippo MR; Martelotto LG; De Mattos-Arruda L; Edelweiss M; Jungbluth AA; Fusco N; Norton L; Weigelt B; Ellis IO; Reis-Filho JS
    J Pathol; 2015 Oct; 237(2):166-78. PubMed ID: 26011570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis.
    Geyer FC; Lacroix-Triki M; Colombo PE; Patani N; Gauthier A; Natrajan R; Lambros MB; Khalifeh I; Albarracin C; Orru S; Marchiò C; Sapino A; Mackay A; Weigelt B; Schmitt FC; Wesseling J; Sneige N; Reis-Filho JS
    Histopathology; 2012 May; 60(6B):E115-30. PubMed ID: 22486256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
    Geyer FC; Berman SH; Marchiò C; Burke KA; Guerini-Rocco E; Piscuoglio S; Ng CK; Pareja F; Wen HY; Hodi Z; Schnitt SJ; Rakha EA; Ellis IO; Norton L; Weigelt B; Reis-Filho JS
    Mod Pathol; 2017 Jan; 30(1):69-84. PubMed ID: 27713419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglandular adenosis: a prime suspect in triple-negative breast cancer development.
    Tsang JY; Tse GM
    J Pathol; 2016 Jun; 239(2):129-32. PubMed ID: 27061094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic and immunohistochemical features of carcinoma involving microglandular adenosis of the breast following neoadjuvant chemotherapy.
    Grabenstetter A; Alfonso TM; Wen HY; Murray M; Brogi E; Tan LK
    Mod Pathol; 2021 Jul; 34(7):1310-1319. PubMed ID: 33649459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma arising in microglandular adenosis of the breast: triple negative phenotype with variable morphology.
    Zhong F; Bi R; Yu B; Cheng Y; Xu X; Shui R; Yang W
    Int J Clin Exp Pathol; 2014; 7(9):6149-56. PubMed ID: 25337263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglandular Adenosis: A Possible Non-Obligate Precursor to Breast Carcinoma With Potential to Either Luminal-Type or Basal-Type Differentiation.
    Damron AT; Korhonen K; Zuckerman S; Tchou J; Dumoff KL; Bleiweiss IJ; Nayak A
    Int J Surg Pathol; 2019 Oct; 27(7):781-787. PubMed ID: 31046496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma.
    Geyer FC; Kushner YB; Lambros MB; Natrajan R; Mackay A; Tamber N; Fenwick K; Purnell D; Ashworth A; Walker RA; Reis-Filho JS
    Histopathology; 2009 Dec; 55(6):732-43. PubMed ID: 19922592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic landscape of adenoid cystic carcinoma of the breast.
    Martelotto LG; De Filippo MR; Ng CK; Natrajan R; Fuhrmann L; Cyrta J; Piscuoglio S; Wen HC; Lim RS; Shen R; Schultheis AM; Wen YH; Edelweiss M; Mariani O; Stenman G; Chan TA; Colombo PE; Norton L; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    J Pathol; 2015 Oct; 237(2):179-89. PubMed ID: 26095796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic features of mammary microglandular adenosis with carcinoma: a study of 5 cases].
    Chen W; Wang C; Zhang ZH; Zhang WM; Xu Y; Song GX
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):530-535. PubMed ID: 28810292
    [No Abstract]   [Full Text] [Related]  

  • 15. Luminal-Type Invasive Carcinoma in Association With Microglandular Adenosis/Atypical Microglandular Adenosis: A Case Report and Molecular Comparison.
    Jaramillo C; Nazario-Toole A; Xia H; Adams T; Josey M
    Cureus; 2023 Apr; 15(4):e37198. PubMed ID: 37159793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Invasive carcinoma arising in breast microglandular adenosis: a clinicopathologic study of three cases and review of the literature].
    Shui RH; Cheng YF; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):471-4. PubMed ID: 22088374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglandular adenosis: a non-obligate precursor of triple-negative breast cancer?
    Wen YH; Weigelt B; Reis-Filho JS
    Histol Histopathol; 2013 Sep; 28(9):1099-108. PubMed ID: 23584829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.
    Fountzilas G; Giannoulatou E; Alexopoulou Z; Zagouri F; Timotheadou E; Papadopoulou K; Lakis S; Bobos M; Poulios C; Sotiropoulou M; Lyberopoulou A; Gogas H; Pentheroudakis G; Pectasides D; Koutras A; Christodoulou C; Papandreou C; Samantas E; Papakostas P; Kosmidis P; Bafaloukos D; Karanikiotis C; Dimopoulos MA; Kotoula V
    Oncotarget; 2016 May; 7(22):32731-53. PubMed ID: 27129168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mutational profiles between triple-negative and hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancers in T2N0-1M0 stage: Implications of TP53 and PIK3CA mutations in Korean early-stage breast cancers.
    Lee S; Kim HY; Jung YJ; Jung CS; Im D; Kim JY; Lee SM; Oh SH
    Curr Probl Cancer; 2022 Apr; 46(2):100843. PubMed ID: 35180531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglandular adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma.
    Schwartz CJ; Dolgalev I; Yoon E; Osman I; Heguy A; Vega-Saenz de Miera EC; Nimeh D; Jour G; Darvishian F
    Hum Pathol; 2019 Mar; 85():65-71. PubMed ID: 30428388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.